The global market for Solid-phase Oligonucleotide Synthesis was valued at US$ 554 million in the year 2024 and is projected to reach a revised size of US$ 1618 million by 2031, growing at a CAGR of 16.8% during the forecast period.
North American market for Solid-phase Oligonucleotide Synthesis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Solid-phase Oligonucleotide Synthesis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Solid-phase Oligonucleotide Synthesis in Commercial is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Solid-phase Oligonucleotide Synthesis include Genescript, GeneArt (Thermofischer), Renesas Electronics Corporation, DNA 2.0 (ATUM), OriGene, BBI, Genewiz, Eurofins Genomics, Gene Oracle, SBS Genetech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Solid-phase Oligonucleotide Synthesis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Solid-phase Oligonucleotide Synthesis.
The Solid-phase Oligonucleotide Synthesis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Solid-phase Oligonucleotide Synthesis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Solid-phase Oligonucleotide Synthesis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Genescript
GeneArt (Thermofischer)
Renesas Electronics Corporation
DNA 2.0 (ATUM)
OriGene
BBI
Genewiz
Eurofins Genomics
Gene Oracle
SBS Genetech
Bio Basic
Segment by Type
Primers
Probes
Intermediate-scale Synthesis Oligos
Large-scale Synthesis Oligos
Linkers and Adaptors
Segment by Application
Commercial
Academic Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Solid-phase Oligonucleotide Synthesis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Primers
1.2.3 Probes
1.2.4 Intermediate-scale Synthesis Oligos
1.2.5 Large-scale Synthesis Oligos
1.2.6 Linkers and Adaptors
1.3 Market by Application
1.3.1 Global Solid-phase Oligonucleotide Synthesis Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Commercial
1.3.3 Academic Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Solid-phase Oligonucleotide Synthesis Market Perspective (2020-2031)
2.2 Global Solid-phase Oligonucleotide Synthesis Growth Trends by Region
2.2.1 Global Solid-phase Oligonucleotide Synthesis Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Solid-phase Oligonucleotide Synthesis Historic Market Size by Region (2020-2025)
2.2.3 Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Region (2026-2031)
2.3 Solid-phase Oligonucleotide Synthesis Market Dynamics
2.3.1 Solid-phase Oligonucleotide Synthesis Industry Trends
2.3.2 Solid-phase Oligonucleotide Synthesis Market Drivers
2.3.3 Solid-phase Oligonucleotide Synthesis Market Challenges
2.3.4 Solid-phase Oligonucleotide Synthesis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Solid-phase Oligonucleotide Synthesis Players by Revenue
3.1.1 Global Top Solid-phase Oligonucleotide Synthesis Players by Revenue (2020-2025)
3.1.2 Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Players (2020-2025)
3.2 Global Solid-phase Oligonucleotide Synthesis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Solid-phase Oligonucleotide Synthesis Revenue
3.4 Global Solid-phase Oligonucleotide Synthesis Market Concentration Ratio
3.4.1 Global Solid-phase Oligonucleotide Synthesis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Solid-phase Oligonucleotide Synthesis Revenue in 2024
3.5 Global Key Players of Solid-phase Oligonucleotide Synthesis Head office and Area Served
3.6 Global Key Players of Solid-phase Oligonucleotide Synthesis, Product and Application
3.7 Global Key Players of Solid-phase Oligonucleotide Synthesis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Solid-phase Oligonucleotide Synthesis Breakdown Data by Type
4.1 Global Solid-phase Oligonucleotide Synthesis Historic Market Size by Type (2020-2025)
4.2 Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Type (2026-2031)
5 Solid-phase Oligonucleotide Synthesis Breakdown Data by Application
5.1 Global Solid-phase Oligonucleotide Synthesis Historic Market Size by Application (2020-2025)
5.2 Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Solid-phase Oligonucleotide Synthesis Market Size (2020-2031)
6.2 North America Solid-phase Oligonucleotide Synthesis Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2020-2025)
6.4 North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Solid-phase Oligonucleotide Synthesis Market Size (2020-2031)
7.2 Europe Solid-phase Oligonucleotide Synthesis Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2020-2025)
7.4 Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size (2020-2031)
8.2 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Region (2020-2025)
8.4 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Solid-phase Oligonucleotide Synthesis Market Size (2020-2031)
9.2 Latin America Solid-phase Oligonucleotide Synthesis Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2020-2025)
9.4 Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size (2020-2031)
10.2 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Country (2020-2025)
10.4 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Genescript
11.1.1 Genescript Company Details
11.1.2 Genescript Business Overview
11.1.3 Genescript Solid-phase Oligonucleotide Synthesis Introduction
11.1.4 Genescript Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.1.5 Genescript Recent Development
11.2 GeneArt (Thermofischer)
11.2.1 GeneArt (Thermofischer) Company Details
11.2.2 GeneArt (Thermofischer) Business Overview
11.2.3 GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Introduction
11.2.4 GeneArt (Thermofischer) Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.2.5 GeneArt (Thermofischer) Recent Development
11.3 Renesas Electronics Corporation
11.3.1 Renesas Electronics Corporation Company Details
11.3.2 Renesas Electronics Corporation Business Overview
11.3.3 Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Introduction
11.3.4 Renesas Electronics Corporation Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.3.5 Renesas Electronics Corporation Recent Development
11.4 DNA 2.0 (ATUM)
11.4.1 DNA 2.0 (ATUM) Company Details
11.4.2 DNA 2.0 (ATUM) Business Overview
11.4.3 DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Introduction
11.4.4 DNA 2.0 (ATUM) Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.4.5 DNA 2.0 (ATUM) Recent Development
11.5 OriGene
11.5.1 OriGene Company Details
11.5.2 OriGene Business Overview
11.5.3 OriGene Solid-phase Oligonucleotide Synthesis Introduction
11.5.4 OriGene Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.5.5 OriGene Recent Development
11.6 BBI
11.6.1 BBI Company Details
11.6.2 BBI Business Overview
11.6.3 BBI Solid-phase Oligonucleotide Synthesis Introduction
11.6.4 BBI Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.6.5 BBI Recent Development
11.7 Genewiz
11.7.1 Genewiz Company Details
11.7.2 Genewiz Business Overview
11.7.3 Genewiz Solid-phase Oligonucleotide Synthesis Introduction
11.7.4 Genewiz Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.7.5 Genewiz Recent Development
11.8 Eurofins Genomics
11.8.1 Eurofins Genomics Company Details
11.8.2 Eurofins Genomics Business Overview
11.8.3 Eurofins Genomics Solid-phase Oligonucleotide Synthesis Introduction
11.8.4 Eurofins Genomics Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.8.5 Eurofins Genomics Recent Development
11.9 Gene Oracle
11.9.1 Gene Oracle Company Details
11.9.2 Gene Oracle Business Overview
11.9.3 Gene Oracle Solid-phase Oligonucleotide Synthesis Introduction
11.9.4 Gene Oracle Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.9.5 Gene Oracle Recent Development
11.10 SBS Genetech
11.10.1 SBS Genetech Company Details
11.10.2 SBS Genetech Business Overview
11.10.3 SBS Genetech Solid-phase Oligonucleotide Synthesis Introduction
11.10.4 SBS Genetech Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.10.5 SBS Genetech Recent Development
11.11 Bio Basic
11.11.1 Bio Basic Company Details
11.11.2 Bio Basic Business Overview
11.11.3 Bio Basic Solid-phase Oligonucleotide Synthesis Introduction
11.11.4 Bio Basic Revenue in Solid-phase Oligonucleotide Synthesis Business (2020-2025)
11.11.5 Bio Basic Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Genescript
GeneArt (Thermofischer)
Renesas Electronics Corporation
DNA 2.0 (ATUM)
OriGene
BBI
Genewiz
Eurofins Genomics
Gene Oracle
SBS Genetech
Bio Basic
听
听
*If Applicable.
